Genetics of the kidney and hypertension

Current Hypertension Reports

Volumn 5, Issue 3, 2003, Pages 273-276

  Watson Jr , Bracie ^a  

^a UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ASPARAGINE; ASPARTIC ACID; GLUCOCORTICOID; HYDROXYSTEROID DEHYDROGENASE; MINERALOCORTICOID; MITOCHONDRIAL DNA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); 11BETA HYDROXYSTEROID DEHYDROGENASE; HSD11B1 PROTEIN, HUMAN;

FAMILY; GENE DELETION; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC SUSCEPTIBILITY; HUMAN; HYPERALDOSTERONISM; LIDDLE SYNDROME; LINKAGE ANALYSIS; MISSENSE MUTATION; OXIDATIVE PHOSPHORYLATION; RENOVASCULAR HYPERTENSION; REVIEW; CHRONIC KIDNEY FAILURE; COMORBIDITY; EPIDEMIOLOGY; ETHNOLOGY; GENETIC LINKAGE; GENETIC PREDISPOSITION; GENETICS; HYPERTENSION; MITOCHONDRION; PHYSIOLOGY;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; COMORBIDITY; DNA, MITOCHONDRIAL; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYDROXYSTEROID DEHYDROGENASES; HYPERTENSION; KIDNEY FAILURE, CHRONIC; LINKAGE (GENETICS); MITOCHONDRIA; SEROEPIDEMIOLOGIC STUDIES;

EID: 0141688135     PISSN: 15226417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11906-003-0032-y     Document Type: Review

References (25)

1. Lifton RP, Dluhy RG, Powers M, et al.: Hereditary hypertension caused by chimaeric gene duplications and ectopic expression of aldosterone synthase. Nat Genet 1992, 2:66-74.
2. Shimkets R, Warnock D, Bositis C, et al.: Liddle's syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell 1994, 79:407-414.
3. Mune T, Rogerson FM, Nikkila H, et al.: Human hypertension caused by mutations in the kidney isozyme of 11beta-hydrox-ysteroid dehydrogenase. Nat Genet 1995, 10:394-399.
4. Edwards, CR, Burt D, McIntyre MA, et al.: Localisation of 11beta-hydroxysteroid dehydrogenase-tissue specific protector of the mineralocorticoid receptor. Lancet 1988, 2:986-989.
5. Funder J.W, Pearce PT, Smith R, Smith AI: Mineralocorticoid action; target tissue specificity is enzyme, not receptor, medicated. Science 1988, 237:268-275.
6. Naray-Fejes-Toth A: 11b-hydroxysteroid dehydrogenase actiivity in the renal target cells of aldosterone. Endocrinology 1991, 129:17-21.
7. Rusvai E, Naray-Fejes-Toth A: A new isoform of 11 beta-hydroxysteroid dehydrogenase in aldosteron target cells. J Biol Chem 1993, 268:10717-10720.
8. Watson B, Bergman S, Myracle A, et al.: Genetic association of 11beta-hydroxysteroid dehydrogenasetype (HSD 11B2) flanking microsatellites with essential hypertension in blacks. Hypertensions 1996, 28:478-482.
9. White PC, Agarwal AK, Li A, et al.: Possible association but no linkage of the HSD 11B2 gene encoding the kidney isoenzyme of 11b-hydroxysteroid dehydrogenase to hypertension in black people. Clin Endocrinol 2001, 55:249-252.
10. Cooper R, Rotimi C: Hypertenion in populations of West African origin: is there a genetic predisposition? J Hypertens 1994, 12:215-227.
11. Bergman S, Key B, Warnock D, Rostand S: Kidney disease in the first degree relatives of African-American with Hypertensive end-stage renal disease. Am J Kidney Dis 1996, 27:341-346.
12. Watson B, Nowak NJ, Myracle AD, et al.: The human angiotensinase C gene (HUMPCP) maps to 11q14 within 700kb of D11S901: a candidate gene for essential hypertension. Genomics 1997, 44:365-367.
13. Watson B, Khan MA, Desmond RA, Bergman S: Mitochondrial DNA mutations in black Americans with hypertension-associated end-stage renal disease. Am J Kidney Dis 2001, 38:529-536.
14. DeStefano AL, Gavras H, Heard-Costa N, et al.: Maternal component in the familial aggregation of hypertension. Clin Genet 2001, 60:13-21.
15. Rebbeck TR, Turner ST, Sing CF: Probability of having hypertension: effects of sex, history of hypertension in parents, and other risk factors. J Clin Epidemiol 1996, 49:727-734.
16. Borhani NO, Slansky D, Gaffey W, Borkman T: Familial aggregation of blood pressure. Am J Epidemiol 1969, 89:537-546.
17. Bengtsson B, Thulin T, Schersten B: Familial resemblance in casual blood pressure-a maternal effect? Clin Sci 1979, 57:279-281.
18. Rotig A, Lehnert A, Rustin P, et al.: Kidney Involvement in Mitochonrial Disorders. Vol 1. St. Louis: Mosby-YearBook; 1995.
19. Majander A, Soumalainen A, Vettenranta K, et al.: Congential hypopalstic anemia, diabetes, and severe renal tubular dysfunction associated with a mitochondrial DNA deletion. Pediatr Res 1991, 30:327-330.
20. Szabolcs MJ, Seigle R, Shanske S, et al.: Mitochondrial DNA deletion: a cause of chronic tubulointerstitial nephropathy. Kidney Int 1994, 45:1388-1396.
21. Austin SA, Vriesendorp FJ, Thandroyen FT, et al.: Expanding the phenotype of the 8344 transfer RNAlysine mithochondrial DNA mutation. Neurology 1998, 51:1447-1450.
22. Sun F, Ashley-Koch AE, Durham Lk, et al.: Testing for contributions of mitochondrial DNA mutations to complex diseases. Genet Epidemiol 1998, 15:451-469.
23. Mansbach AB: Ultrastructure of the Proximal Tubule. Washington, DC: American Physiological Society; 1973.
24. Brenner BM, Chertow GM: Congenital oligonephropathy and the etiology of adult hypertension and progressive renal injury. Am J Kidney Dis 1994 23:171-175.
25. Foremann JW: Pediatric Nephrolog. Baltimore: Williams and Wilkins; 1994.